Industria Biotecnológica Von Meiding, S.A. de C.V.
About Industria Biotecnológica Von Meiding
Description and business orientation. The objective of this business is the production of proteins with high molecular weight (greater than 1.5 kD) and a large number of amino acids, called recombinant proteins, by culturing cell lines.
The production of these active principles in large volumes is achieved by the facility of cell cultures that express the protein to the culture medium, which is subsequently purified to the maximum by means of chromatographic techniques.
- Our policy is to comply with U.S. Federal Regulations, ICH Technical Requirements for Registration of Drugs for Human Use, Guidance for Industry, published by US CDER and CBER, FDA, among others. We are currently working on the engineering design for biotechnological facilities according to cGMP, to be able to produce recombinant active biological molecules produced by eukaryotic cell culture.
- In addition to the above, the functional design of our company will be according to the ISO9001:2000 standard, to ensure the highest level of quality and continuous improvement from the beginning of operations.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in Spanish can be found here.
- Focus : Manufacturer
- Industry : Biotechnology
